ORAMED PHARMACEUTICALS Reports Third Quarter Earnings Results for Fiscal Year 2023
🌥️Earnings Overview On November 9 2023, ORAMED PHARMACEUTICALS ($NASDAQ:ORMP) reported its earnings results for the third quarter of fiscal year [...]
ORAMED PHARMACEUTICALS Reports Record Earnings for FY2023 Q2
🌥️Earnings Overview On August 10 2023, ORAMED PHARMACEUTICALS ($NASDAQ:ORMP) released their financial results for the second quarter of FY2023, ending [...]
Oramed Pharmaceuticals’ Chinese Partner HTIT Completes Phase 3 Trial, Stock Soars 17%!
Trending News 🌥️ Oramed Pharmaceuticals ($NASDAQ:ORMP) has just seen its stock soar a whopping 17% after news that their Chinese [...]
Oramed Pharmaceuticals Intrinsic Value – Oramed Pharmaceuticals Stock Closes at $2.73, Consensus Estimates for Next Quarter Remain Positive
Trending News ☀️ Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc. has recently closed at $2.73, a decrease of -1.44% from the prior session's [...]
ORAMED PHARMACEUTICALS Stockholders Suffer Losses Over the Past Year
Trending News 🌧️ Investors who chose to invest in Oramed Pharmaceuticals ($NASDAQ:ORMP) (NASDAQ:ORMP) over the past year have experienced significant [...]
Oramed Pharmaceuticals Stock Fair Value – 2023: Oramed Pharmaceuticals CEO Purchases $201,000 in Stock in Insider Buying.
Trending News 🌥️ In recent news, Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc. CEO, Nadav Kidron, has purchased $201,000 in stock through insider [...]
Oramed Pharmaceuticals Stock Intrinsic Value – Oramed Pharmaceuticals’ P3 Type 2 Diabetes Trial Fails to Meet Expectations
Trending News 🌧️ Oramed Pharmaceuticals Stock Intrinsic Value - Oramed Pharmaceuticals ($NASDAQ:ORMP) recently announced the results of its Phase 3 [...]
Analysts Offer Predictions for Oramed Pharmaceuticals’ FY2022 Earnings
Trending News 🌥️ Oramed Pharmaceuticals ($NASDAQ:ORMP) is a leading Israeli biopharmaceutical company focused on the development of oral drug delivery [...]
Shareholders of Oramed Pharmaceuticals Express Gratitude for Ongoing Support and Commitment to Innovative Treatments
Trending News ☀️ Oramed Pharmaceuticals Stock Fair Value – Dear Shareholders of Oramed Pharmaceuticals ($NASDAQ:ORMP) Inc., Oramed Pharmaceuticals Inc. is [...]
Alliance Global Partners lowers target price for Oramed Pharmaceuticals
Trending News 🌧️ Alliance Global Partners has lowered its target price for Oramed Pharmaceuticals ($NASDAQ:ORMP) to $35.00 from $38.00. The [...]










